START FREE TRIAL

Cathie Wood Just Dumped $12M of This AI Stock Days Before Earnings; Is She Smarter Than the Market?

AI Summary

🔒 UNLOCK AI SUMMARY WITH FREE TRIAL

START FREE TRIAL

So here’s what caught our eye this week. ARK Invest quietly sold nearly 100,000 shares of CoreWeave (NASDAQ:CRWV) on May 4. That’s roughly $12 million out the door. Two days before earnings. The stock has already surged 75% year-to-date. And May 7 is when the numbers land. The big question on every desk right now: is this a warning shot — or just classic ARK profit-taking ahead of a binary event? Here are four things you need to know before Thursday’s print.

The Cathie Wood Signal: Smart Money Move or Noise?

On May 4, ARK Invest sold 99,692 CoreWeave shares across multiple ETFs. The stock had ripped 56% in the prior month alone. This kind of trim ahead of earnings is classic ARK. Wood tends to build early in a growth story. Then, when valuations stretch and risk-reward narrows, she shaves. This doesn’t read as a bearish call on the business. It reads like disciplined portfolio management ahead of a high-volatility event.

Context matters here. ARK trimmed AMD on the same day. It also sold Teradyne. Meanwhile, it bought Shopify and L3Harris — very different risk profiles. This looks like a…

Continue Reading With Our 7-Day Free Trial

ONLY $10 per month after the trial. Cancel anytime. No sponsors. No conflicts. 100% independent stock research.

Recent Articles

Fiserv Stock Falls 70% As Big Banks Circle Its Debit Network

Let's talk about a name that's had a genuinely...

Rogers MLSE Acquisition Tests Sports Media Ambitions

Rogers Communications (NYSE:RCI) just moved closer to full control...

This Industrial Giant Is Quietly Powering The Entire AI Trade!

Okay, so here's a fun one. The AI trade...

Microsoft’s Xbox Empire Is Cracking — Nadella Can’t Ignore It

Microsoft (NASDAQ:MSFT) is still one of the strongest companies...

Novartis’ $1.5 Billion Myricx Deal Tests Oncology Pipeline

Novartis (NYSE:NVS) has made another clear move toward oncology...

Related Articles

Fiserv Stock Falls 70% As Big Banks Circle Its Debit Network

Let's talk about a name that's had a genuinely...

Rogers MLSE Acquisition Tests Sports Media Ambitions

Rogers Communications (NYSE:RCI) just moved closer to full control...

This Industrial Giant Is Quietly Powering The Entire AI Trade!

Okay, so here's a fun one. The AI trade...

Microsoft’s Xbox Empire Is Cracking — Nadella Can’t Ignore It

Microsoft (NASDAQ:MSFT) is still one of the strongest companies...

Novartis’ $1.5 Billion Myricx Deal Tests Oncology Pipeline

Novartis (NYSE:NVS) has made another clear move toward oncology...

Genuine Parts Breakup: Will O’Reilly Buy NAPA?

Genuine Parts Company (NYSE:GPC) was already planning a major...

SK Hynix Nasdaq Listing: Did The Rally Arrive First?

Hey there. Quick thought experiment before we dive in....

Kroger’s Giant Eagle Acquisition: Scale Or Risk?

Kroger (NYSE:KR) is back in the grocery consolidation spotlight...
spot_img

Related Articles

Popular Categories

spot_imgspot_img